Search

Your search keyword '"Do, Kim-Anh"' showing total 404 results

Search Constraints

Start Over You searched for: Author "Do, Kim-Anh" Remove constraint Author: "Do, Kim-Anh" Database Unpaywall Remove constraint Database: Unpaywall
404 results on '"Do, Kim-Anh"'

Search Results

2. Clonal dominance defines metastatic dissemination in pancreatic cancer

8. A blood-based metabolomic signature predictive of risk for pancreatic cancer

9. Integrated spatial transcriptomics and lipidomics of precursor lesions of pancreatic cancer identifies enrichment of long chain sulfatide biosynthesis as an early metabolic alteration

10. Figure S4 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

11. Figure S2 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

13. Figure S5A from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

14. Figure S1 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

15. Data from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

16. Figure S4 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

17. Data from Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

18. Supplementary Tables 2-4 from Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

19. Figure S2 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

20. Figure S5B from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

21. Figure S5A from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

22. Figure S5B from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

23. Supplementary Table 1 from Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

25. Figure S6 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

26. Data from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

27. Figure S6 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

28. Data from Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

29. Supplementary Tables 2-4 from Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

32. Figure S1 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

33. Figure S3 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

34. Table S1 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

35. Figure S3 from Cooperative Effect of Oncogenic MET and PIK3CA in an HGF-Dominant Environment in Breast Cancer

36. Supplementary Table 1 from Effect of Low-Fat Diets on Plasma Levels of NF-κB–Regulated Inflammatory Cytokines and Angiogenic Factors in Men with Prostate Cancer

37. Supplementary Data from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

38. Supplementary Figure from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

39. Supplementary Figure from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

40. Supplementary Data from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

41. Supplementary Figure from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

42. Supplementary Figure from A Blood-Based Metabolite Panel for Distinguishing Ovarian Cancer from Benign Pelvic Masses

43. Data Supplement from Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer

45. Supplementary Figure 3 from Whole Genome–Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non–Small-Cell Lung Cancer

46. Supplemental R File 4-UK TMA from Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

47. Supplementary Tabes 1, 3 and 4 from Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

48. Data Supplement from Influence of Biospecimen Variables on Proteomic Biomarkers in Breast Cancer

49. Supplementary Table 1-7 from Whole Genome–Derived Tiled Peptide Arrays Detect Prediagnostic Autoantibody Signatures in Non–Small-Cell Lung Cancer

50. Supplemental Figure Legends from Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

Catalog

Books, media, physical & digital resources